Sichuan Biokin Pharmaceutical's Unit Receives Milestone Payment From Bristol-Myers Squibb
BMY•Milestone payment under Iza-bren agreement
Sept. 21 (Reuters) - Sichuan Biokin Pharmaceutical 688506.SS:
- Says unit received $250 million milestone payment from Bristol-Myers Squibb for Iza-bren agreement
